← Back to Search

Behavioral Intervention for Prostate Cancer

N/A
Waitlist Available
Led By Susan Eggly, PhD
Research Sponsored by Barbara Ann Karmanos Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (time 1) to pre-clinic visit (time 2) post-clinic visit (time 3)
Awards & highlights

Study Summary

This trial is testing a way to improve communication between patients and their cancer doctors, by giving patients a brochure with questions to ask their doctor.

Eligible Conditions
  • Prostate Cancer
  • Ovarian Cancer
  • Cervical Cancer
  • Bladder Cancer
  • Breast Cancer
  • Kidney Cancer
  • Lung Cancer
  • Colorectal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (time 1) to pre-clinic visit (time 2) post-clinic visit (time 3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (time 1) to pre-clinic visit (time 2) post-clinic visit (time 3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-efficacy in managing patient-physician interactions
Secondary outcome measures
Change in distress
Change in knowledge related to the patient's cancer and treatment
Change in trust in physicians
+1 more

Side effects data

From 2013 Phase 1 & 2 trial • 16 Patients • NCT01923896
13%
Diarrhea
100%
80%
60%
40%
20%
0%
Study treatment Arm
Behavioral Intervention & DCS
Behavioral Intervention & Placebo

Trial Design

1Treatment groups
Experimental Treatment
Group I: Health services research (ASQ brochure)Experimental Treatment1 Intervention
Patients receive ASQ brochure and complete questionnaires over 30 minutes at baseline, over 10 minutes pre-clinic visit, and over 30 minutes post-clinic visit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Intervention
2021
Completed Phase 4
~3740

Find a Location

Who is running the clinical trial?

Barbara Ann Karmanos Cancer InstituteLead Sponsor
163 Previous Clinical Trials
9,188 Total Patients Enrolled
15 Trials studying Prostate Cancer
1,071 Patients Enrolled for Prostate Cancer
Susan Eggly, PhDPrincipal InvestigatorWayne State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any more openings available for this clinical trial?

"Confirmed. Clinicaltrials.gov is hosting information that this clinical trial posted as of August 25th 2021, and was recently updated on September 22nd 2022, has opened recruitment for 225 patients across 8 sites."

Answered by AI

What is the scope of participants involved in this clinical investigation?

"Affirmative. According to clinicaltrials.gov, this research endeavour is currently enrolling participants and has been since August 25th 2021. The most recent revisions were made on September 22nd 2022 and they are looking for up to 225 patients across 8 sites."

Answered by AI

Where can this experiment be accessed?

"At present, this study is enrolling participants from 8 trial sites. These are located in Clarkston, Bay City and Flint to name a few among other locations that might be more proximal for potential patients."

Answered by AI
~23 spots leftby Mar 2025